Hydroxymethylbutyrate and Eicosapentaenoic Acid: Preclinical Studies to Improve Muscle Function in Critical Care Medicine

This publication has 48 references indexed in Scilit:

• EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype
  Journal of Neuroimmunology, 2013
• Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults
  Clinical Nutrition, 2013
• β-Hydroxy-β-methylbutyrate (HMB) enhances the proliferation of satellite cells in fast muscles of aged rats during recovery from disuse atrophy
  Experimental Gerontology, 2013
• Supplemental intravenous n-3 fatty acids and n-3 fatty acid status and outcome in critically ill elderly patients in the ICU receiving enteral nutrition
  Clinical Nutrition, 2013
• Diaphragm Dysfunction on Admission to the Intensive Care Unit. Prevalence, Risk Factors, and Prognostic Impact—A Prospective Study
  American Journal of Respiratory and Critical Care Medicine, 2013
• β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia
  International Journal of Oncology, 2011
• Year‐long Changes in Protein Metabolism in Elderly Men and Women Supplemented With a Nutrition Cocktail of β‐Hydroxy‐β‐methylbutyrate (HMB), L‐Arginine, and L‐Lysine
  Journal of Parenteral and Enteral Nutrition, 2008
• Dietary toxicity of calcium β-hydroxy-β-methyl butyrate (CaHMB)
  Food and Chemical Toxicology, 2005
• Effect of β-hydroxy-β-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women
  Nutrition, 2004
• ??-hydroxy-??-methylbutyrate ingestion, Part II: effects on hematology, hepatic and renal function
  Medicine & Science in Sports & Exercise, 2000